Connection

Ki Chung to Treatment Outcome

Back to Details
This is a "connection" page, showing publications Ki Chung has written about Treatment Outcome.
Ki Chung
Connection Strength
0.021
Treatment Outcome
  1. A phase 1b study evaluating the safety and preliminary efficacy of berzosertib in combination with gemcitabine in patients with advanced non-small cell lung cancer. Lung Cancer. 2022 01; 163:19-26.
    View in: PubMed
    Score: 0.021
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.